CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Xanomeline

呫诺美林 杂质对照品Xanomeline Impurities

49 个杂质条目49 impurity entries

本页汇总 呫诺美林 的 49 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 49 impurity reference standards of Xanomeline. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 呫诺美林(Xanomeline)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsAnalytical Methods for Xanomeline and Trospium Chloride: A Review and Future Outlook
    Critical reviews in analytical chemistry · 2025 · Velayudhan Kutty S et al.  ·  PMID 40908715  ·  DOI
  2. 分析方法Analytical MethodsDetermination of xanomeline and active metabolite, N-desmethylxanomeline, in human plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
    Journal of chromatography. B, Biomedical applications · 1995 · Murphy AT et al.  ·  PMID 7581862  ·  DOI
  3. 分析方法Analytical MethodsDetermination of xanomeline (LY246708 tartrate), an investigational agent for the treatment of Alzheimer's disease, in rat and monkey plasma by capillary gas chromatography with nitrogen-phosphorus detection
    Journal of chromatography. B, Biomedical applications · 1995 · Brown TJ, Shipley LA  ·  PMID 7795813  ·  DOI
  4. 分析方法Analytical MethodsHigh-performance liquid chromatographic assay for xanomeline, a specific M-1 agonist, and its metabolite in human plasma
    Journal of chromatography. B, Biomedical applications · 1995 · Kasper SC et al.  ·  PMID 7581918  ·  DOI
  5. 分析方法Analytical MethodsNormal-phase liquid chromatography-particle-beam mass spectrometry in drug metabolism studies of the dopamine receptor antagonist Odapipam and the muscarine M1 receptor agonist Xanomeline
    Xenobiotica; the fate of foreign compounds in biological systems · 1997 · Andersen JV, Hansen KT  ·  PMID 9381731  ·  DOI

呫诺美林 —— 原料药与杂质对照品Xanomeline — drug substance & impurities

共 50 个条目(含原料药本体)50 items incl. the drug substance
Xanomeline structure
原料药 APIAPI
呫诺美林Xanomeline
Xanomeline
CAS No.131986-45-3
Chemical FormulaC14H23N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline L-Tartrate structure
—
呫诺美林 L-酒石酸盐Xanomeline L-Tartrate
Xanomeline L-Tartrate
CAS No.152854-19-8
Chemical FormulaC14H23N3OS·C4H6O6
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 1 (Xanomeline N-Oxide) structure
1
呫诺美林杂质1 (呫诺美林氮氧化物)Xanomeline Impurity 1 (Xanomeline N-Oxide)
Xanomeline Impurity 1 (Xanomeline N-Oxide)
CAS No.174656-58-7
Chemical FormulaC14H23N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 2 (N-Desmethyl Xanomeline) structure
2
呫诺美林杂质2 (N-去甲基呫诺美林)Xanomeline Impurity 2 (N-Desmethyl Xanomeline)
Xanomeline Impurity 2 (N-Desmethyl Xanomeline)
CAS No.131986-96-4
Chemical FormulaC13H21N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline  Impurity 3 structure
3
呫诺美林杂质3Xanomeline Impurity 3
Xanomeline Impurity 3
CAS No.174656-57-6
Chemical FormulaC11H15N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline  Impurity 4 structure
4
呫诺美林杂质4Xanomeline Impurity 4
Xanomeline Impurity 4
CAS No.159058-46-5
Chemical FormulaC12H17N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 6 structure
6
呫诺美林杂质6Xanomeline Impurity 6
Xanomeline Impurity 6
CAS No.131986-66-8
Chemical FormulaC15H25N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 7 structure
7
呫诺美林杂质7Xanomeline Impurity 7
Xanomeline Impurity 7
CAS No.2414049-88-8
Chemical FormulaC14H20N3O2S+
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 8 structure
8
呫诺美林杂质8Xanomeline Impurity 8
Xanomeline Impurity 8
CAS No.17604-74-9
Chemical FormulaC7H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 9 Hydrochloride structure
9
呫诺美林杂质9 盐酸盐Xanomeline Impurity 9 Hydrochloride
Xanomeline Impurity 9 Hydrochloride
CAS No.116033-55-7
Chemical FormulaC7H7N3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 9 structure
9
呫诺美林杂质9Xanomeline Impurity 9
Xanomeline Impurity 9
CAS No.131988-63-1
Chemical FormulaC7H7N3
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 10 structure
10
呫诺美林杂质10Xanomeline Impurity 10
Xanomeline Impurity 10
CAS No.131987-69-4
Chemical FormulaC13H17N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 11 structure
11
呫诺美林杂质11Xanomeline Impurity 11
Xanomeline Impurity 11
CAS No.131988-19-7
Chemical FormulaC14H20N3OS+·I-
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 11  Monomer structure
11
呫诺美林杂质11 单体Xanomeline Impurity 11 Monomer
Xanomeline Impurity 11 Monomer
CAS No.759425-28-0
Chemical FormulaC14H20N3OS+
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 21 structure
21
呫诺美林杂质21Xanomeline Impurity 21
Xanomeline Impurity 21
CAS No.2644093-98-9
Chemical FormulaC7H5N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 22 structure
22
呫诺美林杂质22Xanomeline Impurity 22
Xanomeline Impurity 22
CAS No.131987-88-7
Chemical FormulaC7H5N3S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 23 structure
23
呫诺美林杂质23Xanomeline Impurity 23
Xanomeline Impurity 23
CAS No.141064-09-7
Chemical FormulaC14H19N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 26 structure
26
呫诺美林杂质26Xanomeline Impurity 26
Xanomeline Impurity 26
CAS No.131986-29-3
Chemical FormulaC9H13N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 27 structure
27
呫诺美林杂质27Xanomeline Impurity 27
Xanomeline Impurity 27
CAS No.159056-24-3
Chemical FormulaC15H25N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 28 structure
28
呫诺美林杂质28Xanomeline Impurity 28
Xanomeline Impurity 28
CAS No.131987-61-6
Chemical FormulaC8H7N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 29 structure
29
呫诺美林杂质29Xanomeline Impurity 29
Xanomeline Impurity 29
CAS No.1249751-34-5
Chemical FormulaC7H5ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 30 structure
30
呫诺美林杂质30Xanomeline Impurity 30
Xanomeline Impurity 30
CAS No.99233-23-5
Chemical FormulaC7H7N3
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 31 structure
31
呫诺美林杂质31Xanomeline Impurity 31
Xanomeline Impurity 31
CAS No.66719-00-4
Chemical FormulaC7H7N3
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 33 structure
33
呫诺美林杂质33Xanomeline Impurity 33
Xanomeline Impurity 33
CAS No.1783526-70-4
Chemical FormulaC8H5N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 34 structure
34
呫诺美林杂质34Xanomeline Impurity 34
Xanomeline Impurity 34
CAS No.165116-42-7
Chemical FormulaC14H23N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 35 structure
35
呫诺美林杂质35Xanomeline Impurity 35
Xanomeline Impurity 35
CAS No.274688-21-0
Chemical FormulaC18H16N6O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 37 structure
37
呫诺美林杂质37Xanomeline Impurity 37
Xanomeline Impurity 37
CAS No.3061300-18-0
Chemical FormulaC14H23N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 38 structure
38
呫诺美林杂质38Xanomeline Impurity 38
Xanomeline Impurity 38
CAS No.466686-66-8
Chemical FormulaC7H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 39 structure
39
呫诺美林杂质39Xanomeline Impurity 39
Xanomeline Impurity 39
CAS No.466686-68-0
Chemical FormulaC7H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 40 structure
40
呫诺美林杂质40Xanomeline Impurity 40
Xanomeline Impurity 40
CAS No.99310-63-1
Chemical FormulaC7H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 41 structure
41
呫诺美林杂质41Xanomeline Impurity 41
Xanomeline Impurity 41
CAS No.83012-15-1
Chemical FormulaC7H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 42 structure
42
呫诺美林杂质42Xanomeline Impurity 42
Xanomeline Impurity 42
CAS No.1142908-01-7
Chemical FormulaC7H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 43 structure
43
呫诺美林杂质43Xanomeline Impurity 43
Xanomeline Impurity 43
CAS No.154394-30-6
Chemical FormulaC6H6N2
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 44 structure
44
呫诺美林杂质44Xanomeline Impurity 44
Xanomeline Impurity 44
CAS No.131988-25-5
Chemical FormulaC8H7ClN3S+·I-
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 49 structure
49
呫诺美林杂质49Xanomeline Impurity 49
Xanomeline Impurity 49
CAS No.748751-53-3
Chemical FormulaC15H26N3OS+
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 50 structure
50
呫诺美林杂质50Xanomeline Impurity 50
Xanomeline Impurity 50
CAS No.131986-31-7
Chemical FormulaC10H15N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 52 structure
52
呫诺美林杂质52Xanomeline Impurity 52
Xanomeline Impurity 52
CAS No.141064-10-0
Chemical FormulaC13H17N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 53 structure
53
呫诺美林杂质53Xanomeline Impurity 53
Xanomeline Impurity 53
CAS No.159058-55-6
Chemical FormulaC14H20N3OS+·I-
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 55 structure
55
呫诺美林杂质55Xanomeline Impurity 55
Xanomeline Impurity 55
CAS No.141064-14-4
Chemical FormulaC14H23N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 57 structure
57
呫诺美林杂质57Xanomeline Impurity 57
Xanomeline Impurity 57
CAS No.159059-10-6
Chemical FormulaC9H13N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 58 structure
58
呫诺美林杂质58Xanomeline Impurity 58
Xanomeline Impurity 58
CAS No.3061109-19-8
Chemical FormulaC14H25N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 59 structure
59
呫诺美林杂质59Xanomeline Impurity 59
Xanomeline Impurity 59
CAS No.3061109-20-1
Chemical FormulaC14H25N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 64 structure
64
呫诺美林杂质64Xanomeline Impurity 64
Xanomeline Impurity 64
CAS No.131986-33-9
Chemical FormulaC11H17N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 65 structure
65
呫诺美林杂质65Xanomeline Impurity 65
Xanomeline Impurity 65
CAS No.238426-80-7
Chemical FormulaC13H17N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 73 structure
73
呫诺美林杂质73Xanomeline Impurity 73
Xanomeline Impurity 73
CAS No.1491529-06-6
Chemical FormulaC7H4ClN3S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 74 structure
74
呫诺美林杂质74Xanomeline Impurity 74
Xanomeline Impurity 74
CAS No.1483591-15-6
Chemical FormulaC7H4ClN3S
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 77 structure
77
呫诺美林杂质77Xanomeline Impurity 77
Xanomeline Impurity 77
CAS No.141064-12-2
Chemical FormulaC13H17N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 78 structure
78
呫诺美林杂质78Xanomeline Impurity 78
Xanomeline Impurity 78
CAS No.141064-11-1
Chemical FormulaC13H17N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 79 structure
79
呫诺美林杂质79Xanomeline Impurity 79
Xanomeline Impurity 79
CAS No.131987-62-7
Chemical FormulaC9H9N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Xanomeline Impurity 83 structure
83
呫诺美林杂质83Xanomeline Impurity 83
Xanomeline Impurity 83
CAS No.1222434-21-0
Chemical FormulaC14H23N3OS
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

呫诺美林 —— 研究文献与合成路线Xanomeline — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 呫诺美林 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Xanomeline. Titles link to the original records; copyright remains with the authors and publishers.

合成路线文献Synthetic-route papers

  1. The Design, Synthesis and Pharmacological Characterization of Potent Xanomeline-Based M1 and M4 mAChR Bitopic Ligands
    Su Y, Pham V, Kaoullas MG, et al. · Journal of medicinal chemistry · 2026
  2. Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis and FRET Investigation
    Matera C, Kauk M, Cirillo D, et al. · Molecules (Basel, Switzerland) · 2023
  3. Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M1 muscarinic acetylcholine receptors
    Maspero M, Volpato D, Cirillo D, et al. · Bioorganic chemistry · 2020

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

呫诺美林 杂质谱研究要点Xanomeline — impurity profiling notes

下面这些是拿到 呫诺美林 的 50 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 50 impurity entries for Xanomeline, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances